Why Exact Sciences Shares Are Soaring 11.6% Today
After the company reported better-than-expected top- and bottom-line third-quarter results today, shares of Exact Sciences (NASDAQ: EXAS) are jumping 11.6% at 12:30 p.m. EDT.
As many as 20 million Americans between the ages of 50 and 74 are not getting colon cancer screening as often as recommended, and as a result, many patients are diagnosed with advanced colon cancer that could have been detected at an earlier stage, when chances of survival are higher.
IMAGE SOURCE: EXACT SCIENCES.
Source: Fool.com
Exact Sciences Stock
€45.50
-0.140%
With 34 Buy predictions and not a single Sell prediction Exact Sciences is an absolute favorite of our community.
With a target price of 53 € there is a slightly positive potential of 16.48% for Exact Sciences compared to the current price of 45.5 €.
